Mostrando 7 resultados de: 7
Publisher
Nanomaterials(2)
AAPS Advances in the Pharmaceutical Sciences Series(1)
Cancers(1)
Epilepsia Open(1)
International Journal of Pharmaceutics(1)
Área temáticas
Farmacología y terapéutica(7)
Enfermedades(2)
Medicina y salud(2)
Microorganismos, hongos y algas(2)
Cirugía y especialidades médicas afines(1)
Área de conocimiento
Biotecnología(3)
Farmacología(3)
Ciencia de materiales(2)
Nanopartícula(2)
Biomateriales(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(7)
ODS 9: Industria, innovación e infraestructura(6)
ODS 10: Reducción de las desigualdades(1)
Origen
scopus(7)
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
ReviewAbstract: Epilepsy is the second most prevalent neurological disease worldwide. It is mainly characterized byPalabras claves:Epilepsy, lipid nanoparticles, Nanomedicine, nanotechnology, neurodegenerative diseases, Polymeric nanoparticlesAutores:Antoni Camins, Bonilla L., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusArticle dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study
ArticleAbstract: Ocular inflammation is one of the most prevalent diseases in ophthalmology, which can affect variousPalabras claves:Dexibuprofen, Drug delivery system, Nanoparticles, PLGAAutores:Alsafi Z., Antoni Camins, Calpena A.C., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Muñoz M., Ortiz A., Prat J., Pujol M., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusIn vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration
ArticleAbstract: Pranoprofen (PF) is a NSAID considered as a safe anti-inflammatory treatment for strabismus and/or cPalabras claves:Anti-inflammatory efficacy, Corneal permeation, Cytotoxicity cell, Nanoparticles, Poly (lactic/glycolic) acid (PLGA), PranoprofenAutores:Abrego G., Alvarado H., Calpena A.C., Cristina Cañadas, García M.L., Silva A.M., Souto E.M.B.Fuentes:scopusMetal-based nanoparticles as antimicrobial agents: An overview
ReviewAbstract: Metal-based nanoparticles have been extensively investigated for a set of biomedical applications. APalabras claves:AgNPs, Antibacterial activity, AuNPs, CuONPs, Metal-based nanoparticles, ZnONPsAutores:Antoni Camins, Bonilla L., Cano A., Durazzo A., Espina M., Esteruelas G., Ettcheto M., Galindo R., García M.L., Gomes D., Lopez-Machado A.L., Sanchez-Lopez E., Santini A., Silva A.M., Souto E.M.B.Fuentes:scopusLipid nanocarriers for hyperproliferative skin diseases
ReviewAbstract: Hyperproliferative skin diseases (HSD) are a group of diseases that include cancers, pre-cancerous lPalabras claves:Antiproliferative drugs, Hyperproliferative skin diseases, lipid nanoparticles, Liposomes, Skin cancerAutores:Cano A., Chorilli M., de Souza A.L.R., Gremião M.P.D., Karczewski J., Kolenyak Fernanda Dos Santos, Sanchez-Lopez E., Souto E.M.B., Staszewski R., Zielińska A.Fuentes:scopusNanoparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations
Book PartAbstract: Recent developments in nanotechnology have provided an unprecedented opportunity to improve the prevPalabras claves:lipid nanoparticles, Nanoparticles, Ocular drug delivery, PLGA nanoparticles, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusState of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks
ReviewAbstract: Metal nanoparticles have been extensively investigated for different types of pharmaceutical applicaPalabras claves:Metal nanoparticles, Nanoparticles functionalization, Nanoparticles toxicity, Reactive oxygen speciesAutores:Antoni Camins, Barroso E., Cano A., Espina M., Ettcheto M., García M.L., García-Torra V., Sanchez-Lopez E., Souto E.M.B., Vázquez-Carrera M.Fuentes:scopus